138.98
Neurocrine Biosciences Inc 주식(NBIX)의 최신 뉴스
Asia Deal Watch: GSK To Collaborate With LTZ On Myeloid Cell Engagers - Citeline News & Insights
Is Neurocrine Biosciences Inc. (NB3) stock a safe buy pre earningsProfit Target & AI Based Trade Execution Alerts - newser.com
Neurocrine publishes review highlighting differences between tardive dyskinesia treatments By Investing.com - Investing.com South Africa
Neurocrine study highlights differences between tardive dyskinesia drugs - StreetInsider
Neurocrine Biosciences Announces Publication of Landmark Narrative Review on FDA-Approved VMAT2 Inhibitors Demonstrating Unique Profile of INGREZZA® (valbenazine) Capsules - PR Newswire
Can Neurocrine Biosciences Inc. (NB3) stock beat analyst consensusPrice Action & AI Forecasted Entry/Exit Points - newser.com
Will Neurocrine Biosciences Inc. (NB3) stock split increase liquidityPortfolio Performance Summary & AI Driven Price Forecasts - newser.com
How Neurocrine Biosciences Inc. stock reacts to bond yieldsOil Prices & High Yield Stock Recommendations - newser.com
Is Neurocrine Biosciences Inc. (NB3) stock a buy for dividend portfoliosWeekly Market Summary & Expert-Curated Trade Recommendations - newser.com
What makes Neurocrine Biosciences Inc. (NB3) stock appealing to growth investorsJuly 2025 Fed Impact & Long-Term Safe Investment Ideas - newser.com
Can Neurocrine Biosciences Inc. stock weather global recessionJuly 2025 Short Interest & Smart Money Movement Alerts - newser.com
Is Neurocrine Biosciences Inc. (NB3) stock attractive for dividend growth2025 Earnings Surprises & Technical Pattern Recognition Alerts - newser.com
Measuring Neurocrine Biosciences Inc.’s beta against major indicesJuly 2025 WrapUp & Real-Time Volume Trigger Notifications - newser.com
How to build a dashboard for Neurocrine Biosciences Inc. stockJuly 2025 Analyst Calls & Verified Stock Trade Ideas - newser.com
Why Neurocrine Biosciences Inc. (NB3) stock could rally stronglyPortfolio Risk Summary & Real-Time Volume Trigger Notifications - newser.com
How Neurocrine Biosciences Inc. stock responds to policy changes2025 Institutional Moves & Fast Exit Strategy with Risk Control - newser.com
A Strong Crenessity Launch And Muscarinic Pipeline Can Propel Neurocrine Biosciences Further - Seeking Alpha
Will Neurocrine Biosciences Inc. (NB3) stock boost dividends furtherTrade Risk Assessment & AI Powered Market Entry Ideas - newser.com
Responsive Playbooks and the NBIX Inflection - news.stocktradersdaily.com
Neurocrine at Jefferies Conference: Growth and Strategic Plans - Investing.com
Neurocrine Biosciences (Nasdaq: NBIX) Reports Positive Phase 2 Osavampator MDD Data - Stock Titan
Is Neurocrine Biosciences Inc. stock trading near support levelsJuly 2025 Movers & High Accuracy Swing Entry Alerts - newser.com
Is Neurocrine Biosciences Inc. (NB3) stock a buy during volatile marketsRisk Management & Weekly Setup with ROI Potential - newser.com
Is it time to cut losses on Neurocrine Biosciences Inc.Quarterly Trade Summary & Verified Entry Point Signals - newser.com
자본화:
|
볼륨(24시간):